1-3 of 3
Suzanne M Vercauteren, MD PhD
Close
Sort by
Journal Articles

MRD Xenotransplantation Prospectively Identifies Treatment-Selected Acute Lymphoblastic Leukemia Subpopulations with Relapse-Initiating Potential

Nina Rolf, MDPhD, Angela Tsang, Lorraine Liu, Amanda Lorentzian, BSc, Pascal Leclair, MSc, Annette Patterson, PhD, Philipp Lange, PhD, Christopher Maxwell, PhD, Chinten J. Lim, PhD, Ramon Klein Geltink, PhD, Suzanne M. Vercauteren, MD PhD FRCPC, Gregor S. D. Reid, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 12–13.
https://doi.org/10.1182/blood-2020-143408
Published: 2020
Journal Articles

Clinical and Laboratory Features Associated with Flow Cytometric CD49f Expression in Pediatric B Cell Acute Lymphoblastic Leukemia

Eric McGinnis, MD BSc, David Yang, BMLSc, Nina Rolf, MD PhD, Gregor S. D. Reid, PhD, Chinten J. Lim, PhD, Suzanne M. Vercauteren, MD PhD FRCPC
Journal: Blood
Blood (2019) 134 (Supplement_1): 5209.
https://doi.org/10.1182/blood-2019-123590
Published: 2019
Journal Articles

Engraftment and Long-Term Survival at Low Burden of Leukemic Blasts from Primary MRD+ Human Bone Marrow in a Xenotransplant Setting

Nina Rolf, MD PhD, Angela Tsang, BSc, RT, Abbas Fotovati, DVM, PhD, Arnawaz Bashir, PhD, Patrice Eydoux, MD, Suzanne M Vercauteren, MD PhD, Gregor SD Reid, PhD
Journal: Blood
Blood (2016) 128 (22): 1730.
https://doi.org/10.1182/blood.V128.22.1730.1730
Published: 2016